Ru Jia
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology top 10%
- Co-authors
- Qiwen FangLijuan HuangJianming XuRongrui LiuGairong ZhangYan WangZhiyuan HuXin Yi
- Topics
- Neuroendocrine Tumor Research Advances (16 papers)Lung Cancer Research Studies (15 papers)Neuroblastoma Research and Treatments (12 papers)
- Cited by
- OncologyHepatologyImmunology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ru Jia
44 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 833
- Molecular Biology 422
- Immunology 415
- Pulmonary and Respiratory Medicine 318
- Epidemiology 278
Countries citing papers authored by Ru Jia
This map shows the geographic impact of Ru Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Jia more than expected).
Fields of papers citing papers by Ru Jia
This network shows the impact of papers produced by Ru Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Jia. The network helps show where Ru Jia may publish in the future.
Co-authorship network of co-authors of Ru Jia
This figure shows the co-authorship network connecting the top 25 collaborators of Ru Jia. A scholar is included among the top collaborators of Ru Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Jia. Ru Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 24 | |
| 10 | 25 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 115 | |
| 14 | 1 | |
| 15 | 59 | |
| 16 | Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Studybreakdown → | 368 |
| 17 | 34 | |
| 18 | 9 | |
| 19 | 286 | |
| 20 | 35 |
About Ru Jia
Ru Jia is a scholar working on Oncology, Neurology and Immunology, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (16 papers), Lung Cancer Research Studies (15 papers) and Neuroblastoma Research and Treatments (12 papers). The work is most often cited by research in Oncology (833 citations), Hepatology (200 citations) and Immunology (415 citations). Ru Jia has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qiwen Fang, Lijuan Huang, Jianming Xu, Rongrui Liu, Gairong Zhang, Yan Wang, Zhiyuan Hu, Xin Yi, Lianpeng Chang and Yun Zhang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.